55513-0141
Kanjinti
trastuzumab-anns
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Intravenous
TRASTUZUMAB
150.0
mg/7.15mL
55513-0141-01
1 VIAL, SINGLE-DOSE in 1 CARTON (55513-141-01) > 7.15 mL in 1 VIAL, SINGLE-DOSE
Oct. 28, 2019
Immunotherapy
Monoclonal Antibody
HER2
 
In Use